Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial

PHASE3RecruitingINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

August 26, 2021

Primary Completion Date

August 31, 2026

Study Completion Date

May 31, 2027

Conditions
Crohn DiseaseAzathioprineMethotrexate
Interventions
DRUG

AZA capsules

oral AZA capsules at a daily dose of 2.5 mg per kilogram,

DRUG

MTX

MTX 25 mg SC once a week

BIOLOGICAL

blood sample

The lab tests are: serum albumin, C-reactive protein, thrombocytosis and haemoglobin.

Trial Locations (1)

80480

RECRUITING

CHU Amiens, Amiens

All Listed Sponsors
collaborator

Nantes University Hospital

OTHER

collaborator

AP-HP - HU BEAUJON

UNKNOWN

collaborator

CHU REIMS

UNKNOWN

collaborator

Centre Hospitalier Universitaire de Besancon

OTHER

collaborator

CHRU LILLE

UNKNOWN

collaborator

University Hospital, Bordeaux

OTHER

collaborator

Henri Mondor University Hospital

OTHER

collaborator

Hospices Civils de Lyon

OTHER

collaborator

CHU Rennes,France

UNKNOWN

collaborator

CHU ROUEN - HOPITAL DE BOIS-GUILLAUME

UNKNOWN

collaborator

CHRU TOURS

UNKNOWN

collaborator

University Hospital, Toulouse

OTHER

collaborator

University Hospital, Montpellier

OTHER

collaborator

CHU NICE

UNKNOWN

collaborator

CHU NANCY

UNKNOWN

collaborator

CHU CAEN

UNKNOWN

collaborator

CHU SAINT-ETIENNE

UNKNOWN

collaborator

CH TOURCOING

UNKNOWN

collaborator

Hopitaux Civils de Colmar

OTHER

collaborator

CH COTE BASQUE

UNKNOWN

collaborator

CH ROUBAIX

UNKNOWN

collaborator

CHI CRETEIL

UNKNOWN

collaborator

CHI TOULON LA SEYNE

UNKNOWN

collaborator

CH VALENCE

UNKNOWN

collaborator

CMC Ambroise Paré, Pierre Cherest, Hartmann

UNKNOWN

collaborator

University Hospital, Clermont-Ferrand

OTHER

lead

Centre Hospitalier Universitaire, Amiens

OTHER